Among patients with stable CAD or PAD, those with diabetes appear to derive greater absolute benefits from a combination of low-dose rivaroxaban (Xarelto; Bayer/Janssen) and aspirin compared with ...
Antithrombotic therapy in patients with PAD can be a challenge to manage, but a new scientific statement uses patient vignettes to help clinicians link treatment options with patient characteristics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results